-
1
-
-
38149127170
-
Qualification of biomarkers for drug development in organ transplantation
-
Burckart G.J., Amur S., Goodsaid F.M., et al. Qualification of biomarkers for drug development in organ transplantation. Am J Transplant 8 (2008) 267-270
-
(2008)
Am J Transplant
, vol.8
, pp. 267-270
-
-
Burckart, G.J.1
Amur, S.2
Goodsaid, F.M.3
-
2
-
-
34147176482
-
Cytochrome P4503A and TNF-α genotypes are associated with tacrolimus dosing in pediatric heart transplant patients
-
Zheng H., Webber S., Schuetz E., et al. Cytochrome P4503A and TNF-α genotypes are associated with tacrolimus dosing in pediatric heart transplant patients. Hum Immunol 63 Suppl 1 (2002) S15
-
(2002)
Hum Immunol
, vol.63
, Issue.SUPPL. 1
-
-
Zheng, H.1
Webber, S.2
Schuetz, E.3
-
3
-
-
16544365185
-
Genetics of the variable expression of CYP3A in humans
-
Wojnowski L. Genetics of the variable expression of CYP3A in humans. Ther Drug Monit 26 (2004) 192-199
-
(2004)
Ther Drug Monit
, vol.26
, pp. 192-199
-
-
Wojnowski, L.1
-
4
-
-
33845917818
-
Disparate distribution of 16 candidate single nucleotide polymorphisms among racial and ethnic groups of pediatric heart transplant patients
-
Girnita D.M., Webber S.A., Ferrell R., et al. Disparate distribution of 16 candidate single nucleotide polymorphisms among racial and ethnic groups of pediatric heart transplant patients. Transplantation 82 (2006) 1774-1780
-
(2006)
Transplantation
, vol.82
, pp. 1774-1780
-
-
Girnita, D.M.1
Webber, S.A.2
Ferrell, R.3
-
5
-
-
11144358432
-
CYP3A5 and MDR1 genetic polymorphisms and cyclosporine pharmacokinetics after renal transplantation
-
Anglicheau D., Thervet E., Etienne I., et al. CYP3A5 and MDR1 genetic polymorphisms and cyclosporine pharmacokinetics after renal transplantation. Clin Pharmacol Ther 75 (2004) 422-433
-
(2004)
Clin Pharmacol Ther
, vol.75
, pp. 422-433
-
-
Anglicheau, D.1
Thervet, E.2
Etienne, I.3
-
6
-
-
9144245517
-
Tacrolimus dosing in adult lung transplant patients is related to cytochrome P4503A5 gene polymorphism
-
Zheng H., Zeevi A., Schuetz E., et al. Tacrolimus dosing in adult lung transplant patients is related to cytochrome P4503A5 gene polymorphism. J Clin Pharmacol 44 (2004) 135-140
-
(2004)
J Clin Pharmacol
, vol.44
, pp. 135-140
-
-
Zheng, H.1
Zeevi, A.2
Schuetz, E.3
-
7
-
-
31044454408
-
Influence of CYP3A5 gene polymorphisms of donor rather than recipient to tacrolimus individual dose requirement in liver transplantation
-
Yu S., Wu L., Jin J., et al. Influence of CYP3A5 gene polymorphisms of donor rather than recipient to tacrolimus individual dose requirement in liver transplantation. Transplantation 81 (2006) 46-51
-
(2006)
Transplantation
, vol.81
, pp. 46-51
-
-
Yu, S.1
Wu, L.2
Jin, J.3
-
8
-
-
33646439263
-
Tacrolimus dose requirement in relation to donor and recipient ABCB1 and CYP3A5 gene polymorphisms in Chinese liver transplant patients
-
Wei-lin W., Jing J., Shu-sen Z., et al. Tacrolimus dose requirement in relation to donor and recipient ABCB1 and CYP3A5 gene polymorphisms in Chinese liver transplant patients. Liver Transpl 12 (2006) 775-780
-
(2006)
Liver Transpl
, vol.12
, pp. 775-780
-
-
Wei-lin, W.1
Jing, J.2
Shu-sen, Z.3
-
9
-
-
33749984168
-
CYP3A5 and ABCB1 polymorphisms and tacrolimus pharmacokinetics in renal transplant candidates: guidelines from an experimental study
-
Haufroid V., Wallemacq P., VanKerckhove V., et al. CYP3A5 and ABCB1 polymorphisms and tacrolimus pharmacokinetics in renal transplant candidates: guidelines from an experimental study. Am J Transplant 6 (2006) 2706-2713
-
(2006)
Am J Transplant
, vol.6
, pp. 2706-2713
-
-
Haufroid, V.1
Wallemacq, P.2
VanKerckhove, V.3
-
10
-
-
34447549311
-
Tacrolimus pharmacokinetics and pharmacogenetics: influence of adenosine triphosphate-binding cassette B1 (ABCB1) and cytochrome (CYP) 3A polymorphisms
-
Op den Buijsch R.A., Christiaans M.H., Stolk L.M., et al. Tacrolimus pharmacokinetics and pharmacogenetics: influence of adenosine triphosphate-binding cassette B1 (ABCB1) and cytochrome (CYP) 3A polymorphisms. Fundam Clin Pharmacol 21 (2007) 427-435
-
(2007)
Fundam Clin Pharmacol
, vol.21
, pp. 427-435
-
-
Op den Buijsch, R.A.1
Christiaans, M.H.2
Stolk, L.M.3
-
11
-
-
34548628553
-
Pharmacogenetics as a tool for optimising drug therapy in solid organ transplantation
-
Ng F.L., Holt D.W., and MacPhee I.A. Pharmacogenetics as a tool for optimising drug therapy in solid organ transplantation. Expert Opin Pharmacother 8 (2007) 2045-2058
-
(2007)
Expert Opin Pharmacother
, vol.8
, pp. 2045-2058
-
-
Ng, F.L.1
Holt, D.W.2
MacPhee, I.A.3
-
12
-
-
36148985704
-
CYP3A5 and CYP3A4 but not MDR1 single-nucleotide polymorphisms determine long-term tacrolimus disposition and drug-related nephrotoxicity in renal recipients
-
Kuypers D.R., de Jonge H., Naesens M., et al. CYP3A5 and CYP3A4 but not MDR1 single-nucleotide polymorphisms determine long-term tacrolimus disposition and drug-related nephrotoxicity in renal recipients. Clin Pharmacol Ther 82 (2007) 711-725
-
(2007)
Clin Pharmacol Ther
, vol.82
, pp. 711-725
-
-
Kuypers, D.R.1
de Jonge, H.2
Naesens, M.3
-
13
-
-
34548676182
-
Pharmacogenetics of tacrolimus and sirolimus in renal transplant patients: from retrospective analyses to prospective studies
-
Anglicheau D., Legendre C., and Thervet E. Pharmacogenetics of tacrolimus and sirolimus in renal transplant patients: from retrospective analyses to prospective studies. Transplant Proc 39 (2007) 2142-2144
-
(2007)
Transplant Proc
, vol.39
, pp. 2142-2144
-
-
Anglicheau, D.1
Legendre, C.2
Thervet, E.3
-
14
-
-
33745344584
-
CYP3A5*3 influences sirolimus oral clearance in de novo and stable renal transplant recipients
-
Le Meur Y., Djebli N., Szelag J.C., et al. CYP3A5*3 influences sirolimus oral clearance in de novo and stable renal transplant recipients. Clin Pharmacol Ther 80 (2006) 51-60
-
(2006)
Clin Pharmacol Ther
, vol.80
, pp. 51-60
-
-
Le Meur, Y.1
Djebli, N.2
Szelag, J.C.3
-
15
-
-
33645804424
-
Reduced methylprednisolone clearance causing prolonged pharmacodynamics in a healthy subject was not associated with CYP3A5*3 allele or a change in diet composition
-
Lee S.J., Jusko W.J., Salaita C.G., et al. Reduced methylprednisolone clearance causing prolonged pharmacodynamics in a healthy subject was not associated with CYP3A5*3 allele or a change in diet composition. J Clin Pharmacol 46 (2006) 515-526
-
(2006)
J Clin Pharmacol
, vol.46
, pp. 515-526
-
-
Lee, S.J.1
Jusko, W.J.2
Salaita, C.G.3
-
16
-
-
34147109227
-
Influence of the CYP3A5 genotype on tacrolimus pharmacokinetics and pharmacodynamics in young kidney transplant recipients [see comment]
-
Ferraresso M., Tirelli A., Ghio L., et al. Influence of the CYP3A5 genotype on tacrolimus pharmacokinetics and pharmacodynamics in young kidney transplant recipients [see comment]. Pediatr Transplant 11 (2007) 296-300
-
(2007)
Pediatr Transplant
, vol.11
, pp. 296-300
-
-
Ferraresso, M.1
Tirelli, A.2
Ghio, L.3
-
17
-
-
0037693831
-
Tacrolimus dosing in pediatric heart transplant patients is related to CYP3A5 and MDR1 gene polymorphisms
-
Zheng H., Webber S., Zeevi A., et al. Tacrolimus dosing in pediatric heart transplant patients is related to CYP3A5 and MDR1 gene polymorphisms. Am J Transplant 3 (2003) 477-483
-
(2003)
Am J Transplant
, vol.3
, pp. 477-483
-
-
Zheng, H.1
Webber, S.2
Zeevi, A.3
-
18
-
-
34648857526
-
1199G>A and 2677G>T/A polymorphisms of ABCB1 independently affect tacrolimus concentration in hepatic tissue after liver transplantation
-
Elens L., Capron A., Kerckhove V.V., et al. 1199G>A and 2677G>T/A polymorphisms of ABCB1 independently affect tacrolimus concentration in hepatic tissue after liver transplantation. Pharmacogenet Genomics 17 (2007) 873-883
-
(2007)
Pharmacogenet Genomics
, vol.17
, pp. 873-883
-
-
Elens, L.1
Capron, A.2
Kerckhove, V.V.3
-
19
-
-
38149024948
-
Pharmacogenetics of cyclosporine in children suggests an age-dependent influence of ABCB1 polymorphisms
-
Fanta S., Niemi M., Jonsson S., et al. Pharmacogenetics of cyclosporine in children suggests an age-dependent influence of ABCB1 polymorphisms. Pharmacogenet Genomics 18 (2008) 77-90
-
(2008)
Pharmacogenet Genomics
, vol.18
, pp. 77-90
-
-
Fanta, S.1
Niemi, M.2
Jonsson, S.3
-
20
-
-
21444449731
-
ABCB1 genotype of the donor but not of the recipient is a major risk factor for cyclosporine-related nephrotoxicity after renal transplantation
-
Hauser I.A., Schaeffeler E., Gauer S., et al. ABCB1 genotype of the donor but not of the recipient is a major risk factor for cyclosporine-related nephrotoxicity after renal transplantation. J Am Soc Nephrol 16 (2005) 1501-1511
-
(2005)
J Am Soc Nephrol
, vol.16
, pp. 1501-1511
-
-
Hauser, I.A.1
Schaeffeler, E.2
Gauer, S.3
-
21
-
-
0036729669
-
The MDR1 polymorphisms at exons 21 and 26 predict steroid weaning in pediatric heart transplant patients
-
Zheng H., Webber S., Zeevi A., et al. The MDR1 polymorphisms at exons 21 and 26 predict steroid weaning in pediatric heart transplant patients. Hum Immunol 63 (2002) 765-770
-
(2002)
Hum Immunol
, vol.63
, pp. 765-770
-
-
Zheng, H.1
Webber, S.2
Zeevi, A.3
-
22
-
-
11144223846
-
The impact of pharmacogenomic factors on steroid dependency in pediatric heart transplant patients using logistic regression analysis
-
Zheng H.X., Webber S.A., Zeevi A., et al. The impact of pharmacogenomic factors on steroid dependency in pediatric heart transplant patients using logistic regression analysis. Pediatr Transplant 8 (2004) 551-557
-
(2004)
Pediatr Transplant
, vol.8
, pp. 551-557
-
-
Zheng, H.X.1
Webber, S.A.2
Zeevi, A.3
-
23
-
-
48149098366
-
The impact of P-glycoprotein and Mrp2 on mycophenolic acid levels in mice
-
Wang J., Figurski M., Shaw L.M., et al. The impact of P-glycoprotein and Mrp2 on mycophenolic acid levels in mice. Transpl Immunol 19 (2008) 192-196
-
(2008)
Transpl Immunol
, vol.19
, pp. 192-196
-
-
Wang, J.1
Figurski, M.2
Shaw, L.M.3
-
24
-
-
33750346955
-
Multidrug resistance protein 2 genetic polymorphisms influence mycophenolic acid exposure in renal allograft recipients
-
Naesens M., Kuypers D.R., Verbeke K., et al. Multidrug resistance protein 2 genetic polymorphisms influence mycophenolic acid exposure in renal allograft recipients. Transplantation 82 (2006) 1074-1084
-
(2006)
Transplantation
, vol.82
, pp. 1074-1084
-
-
Naesens, M.1
Kuypers, D.R.2
Verbeke, K.3
-
25
-
-
50549089562
-
Impact of inosine 5′-monophosphate dehyrogenase 1,2 and multidrug resistance protein 2 genetic polymorphisms on mycophenolate mofetil-related adverse events in pediatric heart transplant patients
-
Ohmann E.L., Burckart G.J., Chen Y., et al. Impact of inosine 5′-monophosphate dehyrogenase 1,2 and multidrug resistance protein 2 genetic polymorphisms on mycophenolate mofetil-related adverse events in pediatric heart transplant patients. J Heart Lung Transplant 27 (2008) S181
-
(2008)
J Heart Lung Transplant
, vol.27
-
-
Ohmann, E.L.1
Burckart, G.J.2
Chen, Y.3
-
26
-
-
36148991372
-
Influence of SLCO1B1, 1B3, 2B1, and ABCC2 genetic polymorphisms on mycophenolic acid pharmacokinetics in Japanese renal transplant recipients
-
Miura M., Satoh S., Inoue K., et al. Influence of SLCO1B1, 1B3, 2B1, and ABCC2 genetic polymorphisms on mycophenolic acid pharmacokinetics in Japanese renal transplant recipients. Eur J Clin Pharmacol 63 (2007) 1161-1169
-
(2007)
Eur J Clin Pharmacol
, vol.63
, pp. 1161-1169
-
-
Miura, M.1
Satoh, S.2
Inoue, K.3
-
27
-
-
45849107951
-
Clinical pharmacology and pharmacogenetics of thiopurines
-
Sahasranaman S., Howard D., Roy S., et al. Clinical pharmacology and pharmacogenetics of thiopurines. Eur J Clin Pharmacol 64 (2008) 753-767
-
(2008)
Eur J Clin Pharmacol
, vol.64
, pp. 753-767
-
-
Sahasranaman, S.1
Howard, D.2
Roy, S.3
-
28
-
-
42049122605
-
Role of pharmacogenetics of immunosuppressive drugs in organ transplantation
-
Thervet E., Anglicheau D., Legendre C., et al. Role of pharmacogenetics of immunosuppressive drugs in organ transplantation. Ther Drug Monit 30 (2008) 143-150
-
(2008)
Ther Drug Monit
, vol.30
, pp. 143-150
-
-
Thervet, E.1
Anglicheau, D.2
Legendre, C.3
-
29
-
-
47249151375
-
Pharmacogenetics of immunosuppressants: progress, pitfalls, and promises
-
Cattaneo D., Baldelli S., and Perico N. Pharmacogenetics of immunosuppressants: progress, pitfalls, and promises. Am J Transplant 8 (2008) 1374-1383
-
(2008)
Am J Transplant
, vol.8
, pp. 1374-1383
-
-
Cattaneo, D.1
Baldelli, S.2
Perico, N.3
-
30
-
-
34247614888
-
A novel variant L263F in human inosine 5′-monophosphate dehydrogenase 2 is associated with diminished enzyme activity
-
Wang J., Zeevi A., Webber S., et al. A novel variant L263F in human inosine 5′-monophosphate dehydrogenase 2 is associated with diminished enzyme activity. Pharmacogenet Genomics 17 (2007) 283-290
-
(2007)
Pharmacogenet Genomics
, vol.17
, pp. 283-290
-
-
Wang, J.1
Zeevi, A.2
Webber, S.3
-
31
-
-
42349115968
-
IMPDH1 gene polymorphisms and association with acute rejection in renal transplant patients
-
Wang J., Yang J.W., Zeevi A., et al. IMPDH1 gene polymorphisms and association with acute rejection in renal transplant patients. Clin Pharmacol Ther 83 (2008) 711-717
-
(2008)
Clin Pharmacol Ther
, vol.83
, pp. 711-717
-
-
Wang, J.1
Yang, J.W.2
Zeevi, A.3
-
32
-
-
56349149401
-
Progress in the direct application of pharmacogenomics to patient care: sustaining innovation
-
Burckart G.J., Frueh F.W., and Lesko L.J. Progress in the direct application of pharmacogenomics to patient care: sustaining innovation. J Appl Pharmacol 15 (2007) 1-6
-
(2007)
J Appl Pharmacol
, vol.15
, pp. 1-6
-
-
Burckart, G.J.1
Frueh, F.W.2
Lesko, L.J.3
-
33
-
-
56349121045
-
-
Dosage calculation algorithm. Available at: http://www.warfarindosing.org. Barnes-Jewish Hospital at Washington University Medical Center. Accessed November 2, 2008.
-
Dosage calculation algorithm. Available at: http://www.warfarindosing.org. Barnes-Jewish Hospital at Washington University Medical Center. Accessed November 2, 2008.
-
-
-
|